Alvaro Doyle sold $1.4M of VICR
VP and CIO at VICOR CORP. 7,913 shares at an average of $172.83, traded Feb 23, 2026, filed Feb 24, 2026.
Score components
- +15RoleOfficer
- +25Trade size$1.4M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster11 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -17.0%, 3m +75.0%, 6m +2.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001826730-26-000001, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 23, 2026 | MOption exercise Common Stock | +738 | $75.43 | $56k | 780 | Feb 24, 2026 |
| Feb 23, 2026 | SOpen-market sale Common Stock | -738 | $172.83 | $128k | 42 | Feb 24, 2026 |
| Feb 23, 2026 | MOption exercise Common Stock | +1,162 | $60.61 | $70k | 1,204 | Feb 24, 2026 |
| Feb 23, 2026 | SOpen-market sale Common Stock | -1,162 | $172.83 | $201k | 42 | Feb 24, 2026 |
| Feb 23, 2026 | MOption exercise Common Stock | +2,000 | $48.38 | $97k | 2,042 | Feb 24, 2026 |
| Feb 23, 2026 | SOpen-market sale Common Stock | -2,000 | $172.83 | $346k | 42 | Feb 24, 2026 |
| Feb 23, 2026 | MOption exercise Common Stock | +3,000 | $24.15 | $72k | 3,042 | Feb 24, 2026 |
| Feb 23, 2026 | SOpen-market sale Common Stock | -3,000 | $172.83 | $519k | 42 | Feb 24, 2026 |
| Feb 23, 2026 | MOption exercise Common Stock | +1,013 | $69.04 | $70k | 1,055 | Feb 24, 2026 |
| Feb 23, 2026 | SOpen-market sale Common Stock | -1,013 | $172.83 | $175k | 42 | Feb 24, 2026 |
| Feb 23, 2026 | MOption exercise Non Qualified Stock Optionderivative | -738 | $0.00 | $0 | 369 | Feb 24, 2026 |
| Feb 23, 2026 | MOption exercise Non Qualified Stock Optionderivative | -1,162 | $0.00 | $0 | 1,160 | Feb 24, 2026 |
| Feb 23, 2026 | MOption exercise Non Qualified Stock Optionderivative | -2,000 | $0.00 | $0 | 0 | Feb 24, 2026 |
| Feb 23, 2026 | MOption exercise Non Qualified Stock Optionderivative | -3,000 | $0.00 | $0 | 0 | Feb 24, 2026 |
| Feb 23, 2026 | MOption exercise Non Qualified Stock Optionderivative | -1,013 | $0.00 | $0 | 5,000 | Feb 24, 2026 |
Related signals
Other insiders at VICOR CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | VICOR CORP | Philip D Davies Corp. VP-Global Sales & Mktg. | $972k 3,072 shares | -62% | |
| 38Weak | VICOR CORP | Patrizio Vinciarelli Chairman & CEO | $6.3M 20,000 shares | -0% | |
| 38Weak | VICOR CORP | Patrizio Vinciarelli Chairman & CEO | $6.2M 20,000 shares | -0% | |
| 19Weak | VICOR CORP | Philip D Davies Corp. VP-Global Sales & Mktg. | $546k 3,073 shares | -62% | |
| 48Moderate | VICOR CORP | Zmira Lavie director | $227k 908 shares | -100% | |
| 58Moderate | VICOR CORP | Samuel J Anderson director | $524k 2,073 shares | -34% | |
| 35Weak | VICOR CORP | Philip D Davies Corp. VP-Global Sales & Mktg. | $650k 3,072 shares | -62% | |
| 41Moderate | VICOR CORP | Zmira Lavie director | $273k 1,216 shares | -100% | |
| 32Weak | VICOR CORP | Patrizio Vinciarelli Chairman & CEO | $212k 700 shares | -0% | |
| 40Moderate | VICOR CORP | Philip D Davies Corp. VP-Global Sales & Mktg. | $1.1M 3,073 shares | -62% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.